Nixar (Bilastine)

Bilastine, the active ingredient in Nixar, is an antihistamine presented as an oral tablet for oral use. It alleviates symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents by blocking peripheral H1 receptors, and is available without prescription in many EU countries.

GNH USA supplies Nixar as a licensed, GDP‑compliant international pharmaceutical product, adhering to EU quality standards and regulatory requirements. The company serves hospitals, pharmacies and clinics worldwide, providing reliable sourcing, batch traceability and support for procurement teams across multiple markets.

Bilastine is an antihistamine that acts on the histamine H1‑receptor pathway to relieve allergic conditions.

Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea. Chronic idiopathic urticaria: decreases wheal formation and itching associated with hives. Allergic rhinoconjunctivitis: alleviates ocular itching, redness and watery discharge.

Bilastine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Headache - Mild drowsiness - Dry mouth - Fatigue - Gastrointestinal discomfort (nausea, abdominal pain) - Dizziness

Serious or Rare Side Effects: - Anaphylactic reaction - Severe cutaneous adverse reactions (e.g., Stevens‑Johnson syndrome) - Cardiac arrhythmias - Hepatic injury - Angioedema - Severe hypotension

Before using Nixar, consider the following precautions. - Pregnancy: consult a healthcare professional; data are limited. - Breastfeeding: use with caution as the drug may be excreted in milk. - Renal impairment: dose adjustment may be required in severe cases. - Elderly patients: monitor for increased sedation or dizziness. - Concomitant drugs: review potential interactions, especially with strong CYP inhibitors. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Bilastine may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Ketoconazole: can raise bilastine plasma concentrations. - Erythromycin: may increase systemic exposure. - Ritonavir: strong CYP3A4 inhibitor that elevates levels. - Antacids containing aluminum or magnesium: reduce oral absorption.

Moderate Interactions (Monitor Closely):\n- Alcohol: may enhance drowsiness. - Other antihistamines: additive sedation possible. - Central nervous system depressants (e.g., benzodiazepines): monitor for excessive sedation.